| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancer
|
Voskoboynik, M.
|
|
|
23 |
10 |
p. 2633-2637
|
artikel
|
| 2 |
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer
|
Morris, M.J.
|
|
|
23 |
10 |
p. 2714-2719
|
artikel
|
| 3 |
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers
|
Brouckaert, O.
|
|
|
23 |
10 |
p. 2578-2584
|
artikel
|
| 4 |
Association of telomerase expression with recurrence of sacral chordoma
|
Hu, H.
|
|
|
23 |
10 |
p. 2772
|
artikel
|
| 5 |
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma
|
Morschhauser, F.
|
|
|
23 |
10 |
p. 2687-2695
|
artikel
|
| 6 |
Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?
|
Hemminki, K.
|
|
|
23 |
10 |
p. 2720-2724
|
artikel
|
| 7 |
Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphoma
|
Stevens, W.B.C.
|
|
|
23 |
10 |
p. 2676-2681
|
artikel
|
| 8 |
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes
|
Humbert, O.
|
|
|
23 |
10 |
p. 2572-2577
|
artikel
|
| 9 |
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study
|
Leahy, M.
|
|
|
23 |
10 |
p. 2763-2770
|
artikel
|
| 10 |
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
|
|
|
|
23 |
10 |
p. 2773
|
artikel
|
| 11 |
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
|
Terpos, E.
|
|
|
23 |
10 |
p. 2681-2686
|
artikel
|
| 12 |
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer
|
Ajani, J.A.
|
|
|
23 |
10 |
p. 2638-2642
|
artikel
|
| 13 |
Cognitive changes in multiethnic Asian breast cancer patients: a focus group study
|
Cheung, Y.T.
|
|
|
23 |
10 |
p. 2547-2552
|
artikel
|
| 14 |
Cognitive complaints in women with breast cancer: cross-cultural considerations
|
Ribi, K.
|
|
|
23 |
10 |
p. 2475-2478
|
artikel
|
| 15 |
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model
|
Salah, S.
|
|
|
23 |
10 |
p. 2649-2655
|
artikel
|
| 16 |
Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM
|
Hadji, P.
|
|
|
23 |
10 |
p. 2566-2572
|
artikel
|
| 17 |
Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases
|
de Boer, M.
|
|
|
23 |
10 |
p. 2585-2591
|
artikel
|
| 18 |
Dietary folates and cancer risk in a network of case–control studies
|
Tavani, A.
|
|
|
23 |
10 |
p. 2737-2742
|
artikel
|
| 19 |
Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies
|
Aune, D.
|
|
|
23 |
10 |
p. 2536-2546
|
artikel
|
| 20 |
Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands
|
Haasbeek, C.J.A.
|
|
|
23 |
10 |
p. 2743-2747
|
artikel
|
| 21 |
Editorial board
|
|
|
|
23 |
10 |
p. ii-iii
|
artikel
|
| 22 |
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|
Schmoll, H.J.
|
|
|
23 |
10 |
p. 2479-2516
|
artikel
|
| 23 |
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
|
Ahn, H.K.
|
|
|
23 |
10 |
p. 2703-2707
|
artikel
|
| 24 |
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
|
Lindemann, K.
|
|
|
23 |
10 |
p. 2613-2619
|
artikel
|
| 25 |
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
|
Ladoire, S.
|
|
|
23 |
10 |
p. 2552-2561
|
artikel
|
| 26 |
Geographic distribution of hematopoietic cancers in the Nile delta of Egypt
|
Herzog, C.M.
|
|
|
23 |
10 |
p. 2748-2755
|
artikel
|
| 27 |
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer
|
Schou, J.V.
|
|
|
23 |
10 |
p. 2627-2633
|
artikel
|
| 28 |
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases
|
Golfinopoulos, V.
|
|
|
23 |
10 |
p. 2725-2730
|
artikel
|
| 29 |
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891
|
Lefebvre, J.-L.
|
|
|
23 |
10 |
p. 2708-2714
|
artikel
|
| 30 |
Long-term cosmetic changes after breast-conserving treatment of patients with stage I–II breast cancer and included in the EORTC ‘boost versus no boost’ trial
|
Immink, J.M.
|
|
|
23 |
10 |
p. 2591-2598
|
artikel
|
| 31 |
mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions
|
Villarreal-Garza, C.
|
|
|
23 |
10 |
p. 2526-2535
|
artikel
|
| 32 |
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?
|
Glynne-Jones, R.
|
|
|
23 |
10 |
p. 2517-2526
|
artikel
|
| 33 |
Novel therapies for advanced prostate cancer: have we have widened the goal posts too far?
|
Raghavan, D.
|
|
|
23 |
10 |
p. 2473-2475
|
artikel
|
| 34 |
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study
|
Collea, R.P.
|
|
|
23 |
10 |
p. 2599-2605
|
artikel
|
| 35 |
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
|
Seront, E.
|
|
|
23 |
10 |
p. 2663-2670
|
artikel
|
| 36 |
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
|
Kasenda, B.
|
|
|
23 |
10 |
p. 2670-2675
|
artikel
|
| 37 |
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
|
Janjigian, Y.Y.
|
|
|
23 |
10 |
p. 2656-2662
|
artikel
|
| 38 |
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
|
Ruers, T.
|
|
|
23 |
10 |
p. 2619-2626
|
artikel
|
| 39 |
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience
|
Le Gouill, S.
|
|
|
23 |
10 |
p. 2695-2703
|
artikel
|
| 40 |
Relevant impact of central pathology review on nodal classification in individual breast cancer patients
|
Vestjens, J.H.M.J.
|
|
|
23 |
10 |
p. 2561-2566
|
artikel
|
| 41 |
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306
|
Pietrantonio, F.
|
|
|
23 |
10 |
p. 2771-2772
|
artikel
|
| 42 |
Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma
|
van der Gaag, N.A.
|
|
|
23 |
10 |
p. 2642-2649
|
artikel
|
| 43 |
Table of Contents
|
|
|
|
23 |
10 |
p. iv-vii
|
artikel
|
| 44 |
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy
|
Hanker, L.C.
|
|
|
23 |
10 |
p. 2605-2612
|
artikel
|
| 45 |
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery
|
Yun, Y.H.
|
|
|
23 |
10 |
p. 2731-2737
|
artikel
|
| 46 |
Trends in cancer mortality in China: an update
|
Guo, P.
|
|
|
23 |
10 |
p. 2755-2762
|
artikel
|
Tijdschrift beschrijving